Clinical Trials Directory

Trials / Unknown

UnknownNCT01137942

The Role of Cathepsin X in Infection With the Helicobacter Pylori

Helicobacter Pylori and Gastric Cancer - the Role of Cytokine Polymorphism, Cytokine Expression and Expression of TLR on Persistence of Helicobacter Pylori Infection and Development of Gastric Cancer.

Status
Unknown
Phase
Study type
Observational
Enrollment
14 (estimated)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators want to demonstrate the importance of cathepsin X (CTSX), a cysteine protease, for the Hp eradication success. The diversity of the innate immune response to H. pylori antigens leading to either successful eradication of the infection or maintenance of chronic inflammation is connected to CTSX. The aim of this study is to determine whether H. pylori suppresses the CTSX expression and cytokine secretion in macrophage cell line THP-1 in the individuals that are not capable of eradicating the infection, opposite to H pylori in patients with successful H pylori eradication . The investigators also investigate the possibility whether strain-dependent differences in H. pylori lipopolysaccharide (LPS) influence the CTSX expression and cytokine secretion.

Conditions

Interventions

TypeNameDescription
DRUGclarithromycin, metronidazole, proton pump inhibitorappropriate dose of antibiotics and proton pump inhibitor

Timeline

Start date
2008-11-01
Primary completion
2009-12-01
Completion
2010-07-01
First posted
2010-06-07
Last updated
2010-07-12

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT01137942. Inclusion in this directory is not an endorsement.

The Role of Cathepsin X in Infection With the Helicobacter Pylori (NCT01137942) · Clinical Trials Directory